Probiotics, cecal microflora, and aberrant crypts in the rat colon

Area of Science:

• Gastroenterology
• Microbiology
• Cancer Research

Background:

• Aberrant crypts in the distal colon are precancerous lesions.
• Probiotics, including bifidobacteria and Lactobacillus acidophilus, are investigated for their potential chemopreventive effects.
• Fructooligosaccharides (FOS) can modulate gut microbiota composition.

Purpose of the Study:

• To investigate the effects of bifidobacteria and Lactobacillus acidophilus, alone or in combination with fructooligosaccharides (FOS), on the formation of aberrant crypts induced by 1,2-dimethylhydrazine (DMH) in rats.
• To assess the impact of these interventions on gut microbial populations, specifically bifidobacteria, Lactobacillus acidophilus, and Clostridium perfringens.

Main Methods:

• Rats were administered DMH and treated with skim milk (control), bifidobacteria, L. acidophilus, FOS, or combinations thereof.
• Aberrant crypts and foci in the distal colon were quantified.
• Gut microbial populations (bifidobacteria, C. perfringens) were enumerated.

Main Results:

• Bifidobacteria + FOS administration significantly decreased aberrant crypts in some experiments.
• FOS supplementation increased cecal bifidobacteria and decreased C. perfringens.
• L. acidophilus did not significantly alter aberrant crypt numbers, but bifidobacteria and L. acidophilus reduced C. perfringens.
• A significant correlation was observed between rat body weight and the reduction in aberrant crypts with Bifido-FOS treatment.

Conclusions:

• Bifidobacteria and L. acidophilus show variable effects on aberrant crypt formation in response to DMH.
• Probiotic administration, particularly in combination with FOS, may reduce aberrant crypts and C. perfringens levels.
• Further research is needed to understand the variability in probiotic efficacy and their mechanisms of action in chemoprevention.